Our research focus
Advancing cancer research for patients’ benefit
At the Anticancer Fund, our commitment to combatting cancer is anchored in a strategic focus on clinical research.
By initiating and facilitating research projects, we contribute to the long-term progress of the fight against cancer.
Clinical research is our core activity
We are an independent, non-profit intermediary working with universities, hospitals and researchers to set up clinical trials.
Our trials focus on therapy avenues with limited commercial value for the pharma industry but potential societal value.
As an impact-driven organisation, we select trials that can bring new treatment options to patients as rapidly as possible.
The Anticancer Fund supported more than 30 trials so far.
How we support clinical trials
The Anticancer Fund provides financial support to researchers and institutions conducting clinical trials.
We regularly run Requests for Application that have distinct selection criteria.
Explore our current requests by clicking on the button here below.
Our approach to clinical research
The clinical trials we support are the cornerstone of our pursuit of better outcomes for people facing cancer. Here’s how we make a difference:
Prioritising societal value: We champion therapy avenues that may lack broad commercial appeal for the pharmaceutical industry, but hold significant societal value.
Swift access to treatments: We foster clinical trials designed to bring new treatment options to patients rapidly.
Meticulous resource allocation: Clinical trials are costly, therefore we allocate our resources preciously, funding only those endeavours that align with the conviction of the experts and the patients we consult upfront, and of our team of dedicated doctors and scientists.
Global impact: Results from a clinical study conducted in one country are relevant to patients worldwide. Therefore, our portfolio of trials is international.
